
Buprigesic 10mg Transdermal Patch
Marketer
Neon Laboratories Ltd
Salt Composition
Buprenorphine (10mg)
Overview Buprigesic 10mg Transdermal Patch
Belbuca 10mg transdermal patches effectively manage moderate to severe pain and opioid addiction. They alleviate withdrawal symptoms associated with opioid cessation. Your physician will provide detailed application instructions; adhere closely for optimal results. Dosage and treatment length are individualized based on your condition and response. Maintain consistent use; discontinue only as directed by your doctor. Common side effects include nausea, constipation, headache, dizziness, and drowsiness, potentially more frequent initially or with dosage increases. These usually subside with continued use; however, persistent or severe side effects warrant patch removal and immediate medical consultation. Inform your doctor of any pre-existing health conditions or medications you're currently using, as interactions may occur. Pregnant or breastfeeding individuals must seek medical advice prior to use.
Primary Ingredients of Buprigesic 10mg Transdermal Patch
No text provided. Please provide the text you wish me to rephrase.
Uses of Buprigesic 10mg Transdermal Patch
Morphine addiction; management of significant to intense pain
Major Benefits of Buprigesic 10mg Transdermal Patch:
Follow your doctor's instructions precisely regarding dosage and treatment length. Always verify the product information on the packaging. Apply only to clean, dry skin. Peel away the patch's protective covering, avoiding contact with the adhesive surface. Affix the patch firmly to the skin with the adhesive side facing down.
Common Side effects of Buprigesic 10mg Transdermal Patch:
- Headache
- Back pain
- Drowsiness
- Vomiting
- Insomnia (difficulty in sleeping)
- Dizziness
- Abdominal pain
- Weakness
- Sweating
- Constipation
- Withdrawal syndrome
- Infection
- Vertigo
- Inflammation of the nose
- Chills
- Flu-like symptoms
- Nausea
How to use Buprigesic 10mg Transdermal Patch:
Follow your doctor's instructions precisely regarding dosage and treatment length. Always verify the product information before application. Apply only to clean, dry skin. Peel away the patch's protective covering, avoiding contact with the adhesive surface. Adhere the patch firmly to the skin with the sticky side facing downwards, ensuring even contact.
How Buprigesic 10mg Transdermal Patch works:
Belbuca 10mg transdermal system, a partial opioid agonist, mitigates opioid withdrawal by mimicking opioid effects. It also alleviates pain through interactions with central nervous system receptors, modifying pain perception and response.
SAFETY ADVICE
AlcoholNone
No known drug interactions.
PregnancyCONSULT YOUR DOCTOR
The use of Buprigesic 10mg Transdermal Patches during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Buprigesic 10mg Transdermal Patches while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a possible risk to the infant.
DrivingNone
No known drug interactions.
KidneyCAUTION
Transdermal Buprigesic 10mg patches require careful administration in individuals with advanced renal impairment. Dosage modification for Buprigesic 10mg transdermal patches might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe liver disease should use the Buprigesic 10mg transdermal patch cautiously. Dosage modification of the Buprigesic 10mg transdermal patch might be necessary. Physician consultation is advised. An alternative pain reliever offering greater dosing flexibility may be preferable for individuals with significant hepatic dysfunction.
What if you forget to take Buprigesic 10mg Transdermal Patch :
NA
Facts to Know About Buprigesic 10mg Transdermal Patch
| Label | Value |
|---|---|
| Chemical Type | Phenanthrene Derivatives |
| Developing Habits | . |
| Treatment Category | Neuroscience of the Central Nervous System |
